Lantern Pharma Inc. Deferred Costs, Noncurrent
Lantern Pharma Inc. (LTRN) had Deferred Costs, Noncurrent of $54.83 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-08-14
- 2026-06-30: Deferred Costs, Noncurrent $54.83K.
- 2026-03-31: Deferred Costs, Noncurrent $54.83K.
- 2025-12-31: Deferred Costs, Noncurrent $88.43K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2026-06-30 | $54.83K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $54.83K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $88.43K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |